Viewing nowCombinationCombirocan Tablets 10/16 milligrams
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.

MFDS item code 201702401 · Approved 2017.05.16 · Insurance code 657203110
Treatment of hypertension and heart failure, improvement of hyperlipidemia, and suppression of the progression of atherosclerosis and cardiovascular risk
This drug is used for patients who require simultaneous administration of two components, Candesartan Cilexetil and Rosuvastatin. Candesartan Cilexetil is primarily used in patients with essential hypertension and heart failure having left ventricular dysfunction when additional treatment with ACE inhibitors is needed or poorly tolerated. Rosuvastatin helps with the treatment of dyslipidemia disorders such as primary hypercholesterolemia and mixed dyslipidemia that cannot be controlled by diet and exercise alone. Furthermore, it lowers total cholesterol and LDL cholesterol levels, delays the progression of atherosklerosis, and is used to reduce the risk of cardiovascular disease. It is particularly effective in reducing the risk of stroke, myocardial infarction, and vascular revascularization surgery in middle-aged patients with elevated high-sensitivity C-reactive protein levels and additional cardiovascular risk factors. Therefore, this drug is used to improve hypertension, heart failure, and the risk of cardiovascular diseases related to dyslipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil, taken orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful caution in patients at high risk of hypotension, such as those with volume depletion. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of 2 weeks or longer and increased to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and should continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. For patients taking candesartan cilexetil and rosuvastatin concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration.
Safety and efficacy have not been established in adolescents and children 18 years of age or younger. Safety and efficacy have not been established in adolescents and children 18 years of age or younger.
This drug can cause serious harm to the fetus and newborn if used during pregnancy; therefore, it must be discontinued immediately if pregnancy is confirmed. Do not take this drug if you have an allergy to this drug or any of its components, have severely impaired liver function, are pregnant or breastfeeding, or have a muscular disorder. Elderly patients or those with slightly impaired liver function, elevated potassium levels in the blood, or with heart or kidney disease should use this drug cautiously and require regular testing as directed by a physician. If symptoms such as muscle pain, weakness, or cramps occur, consult a doctor immediately, and in severe cases, discontinue use. It is important to regularly check liver function tests and muscle enzyme (CK) levels while taking this medication. Interactions may occur with other blood pressure medications, diuretics, anticoagulants, antibiotics, and multiple other drugs, so all medications being taken should be reported to the doctor. Women planning to become pregnant or who may be pregnant must use appropriate contraception, and breastfeeding women should avoid using this medication. This drug has not been proven safe and effective in children, and its use is not recommended. In case of overdose, symptoms such as low blood pressure, dizziness, and rapid heartbeat may occur, and if these occur, visit a hospital immediately for appropriate treatment. Caution should be exercised when driving or operating machinery as temporary dizziness or fatigue may occur.
Headache, nasopharyngitis, localized infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, increased blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, chest discomfort, dizziness, positional vertigo, miliaria, periodontitis, inflammation, foreign body sensation, nausea, increased blood sugar, decreased serum sodium, paralysis, muscle tension, syncope, facial flushing, weight gain, facial edema, dry mouth, sleep disturbance, decreased libido, forgetfulness, loss of appetite, increased appetite, tinnitus, taste disturbance, erectile dysfunction, vascular edema, constipation, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbance, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, reduced memory, forgetfulness, amnesia, memory disorders, confusion, myasthenia gravis, ocular myasthenia, hypotension, hyperkalemia, renal impairment, increased creatinine, elevated urea, increased potassium, decreased sodium, elevated ALT, dizziness, altered perception, dyspepsia, gastroenteritis, tachycardia, palpitations, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, depression, drowsiness, dyspnea, rash, increased sweating, hematuria, weakness, fever, dizziness, headache, arthralgia, myalgia, low back pain, acute renal failure, rhabdomyolysis, myopathy, myalgia, increased CK, elevated ALT, elevated AST, malaise, joint pain, fatigue, numbness, sensory disturbance, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, dizziness, cough, nausea, diarrhea, hepatitis, jaundice, rash, urticaria, vascular edema, rhabdomyolysis, arthralgia, myalgia, low back pain, renal impairment, acute renal failure, interstitial pneumonia, shock, syncope, loss of consciousness, paralysis, muscle tension, syncope, facial flushing, weight gain, facial edema, dry mouth, sleep disturbance, decreased libido, forgetfulness, loss of appetite, increased appetite, tinnitus, taste disturbance, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve its effectiveness.
Yellow round film-coated tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Hwanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.